May 16
|
S&P 500 Gains & Losses Today: Index Notches 5-Day Win Streak Despite Consumer Sentiment Slide
|
May 16
|
Was Jim Cramer Right About Moderna (MRNA) Stock?
|
May 16
|
Moderna (NasdaqGS:MRNA) Begins Phase 1 Study on Novel Cancer Therapy Candidate
|
May 16
|
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
|
May 14
|
MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue Shortfall
|
May 14
|
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses
|
May 14
|
Moderna, Inc. (MRNA): Among the Best Growth Stocks to Buy and Hold for the Long Term
|
May 12
|
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know
|
May 12
|
Trump expected to sign order to slash US drug prices
|
May 12
|
Why Moderna Merged Its Tech and HR Departments
|
May 10
|
Moderna, Inc. (MRNA): Among Billionaire David E. Shaw’s Small-Cap Stock Picks with Huge Upside Potential
|
Apr 25
|
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|
Apr 24
|
Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
Apr 24
|
3 Healthcare Stocks Facing Headwinds
|
Apr 24
|
Flagship’s latest venture reflects more than 25 years of leaping into the unknown
|
Apr 23
|
Why vaccine makers aren't worried about Trump administration cuts
|
Apr 20
|
Where Will Moderna Be in 5 Years?
|
Apr 17
|
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
|
Apr 17
|
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
|
Apr 17
|
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59
|